Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice

Clinical and Experimental Immunology

Volumn 132, Issue 1, 2003, Pages 46-52

  Bruley Rosset, M ^a,d   Tieng, V ^b   Charron, D ^b   Toubert, Antoine ^b,c  

^a HÔPITAL PAUL BROUSSE   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

^d Lab Francais Fractionnement B   (France)

Author keywords

Allogeneic bone marrow transplantation; Cytotoxic T lymphocytes; Graft versus host disease; Minor histocompatibility antigens; Peptide elution

Indexed keywords

ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; ELUTION; EXTRACTION; FEMALE; FRACTIONATION; GRAFT VERSUS HOST REACTION; HEART; IMMUNE RESPONSE; IMMUNIZATION; INTESTINE; KIDNEY; LIVER; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN; SPLEEN; TARGET CELL; TARGET ORGAN; TISSUE DEGENERATION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY;

ANIMALS; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTESTINES; KIDNEY; LIVER; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED STRAINS; MYOCARDIUM; SKIN; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037390370     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02115.x     Document Type: Article

References (29)

1. Deeg H, Storb R. Graft versus host disease; pathological and clinical aspects. Annu Rev Med 1984; 35:11-6.
2. Korngold R, Sprent J. Lethal GVHD across minor hiscompatibility barriers, nature of the effector and role of H-2 complex. Immunol Rev 1983; 71:5-16.
3. Wallny H, Rammensee HG. Identification of classical minor histocompatibility antigens as cell-derived peptides. Nature 1990; 343:275-8.
4. Miconnet I, de la Selle V, Tucek C et al. Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR. Immunogenetics 1994; 39:178-86.
5. Wettstein PJ, Colombo MP. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens. J Immunol 1987; 139:2166-71.
6. de Bueger M, Bakker A, Van Rood JJ et al. Tissue distribution of human minor histocompatibility antigens. J Immunol 1992; 149:1788-94.
7. doml) encoded by the classical H7 minor histocompatibility locus. J Immunol 1999; 162:4502-10.
8. van Els C, D'Amaro J, Pool J et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992; 35:161-5.
9. de Bueger M, Verreck M, Blockland E et al. Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide. Eur J Immunol 1993; 23:614-8.
10. Poindexter NJ, Naziruddin B, McCourt DW et al. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A-3-restricted human CTL. J Immunol 1995; 154:3880-7.
11. Wang W, Meadows LR, den Haan JM et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995; 269:1588-92.
12. Brickner AG, Warren EH, Caldwell JA et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001; 193:195-6.
13. Rötzschke O, Falk K, Wallny HJ et al. Characterization of naturally occuring minor histocompatibility peptides including H-4 and H-Y. Science 1990; 249:283-7.
14. Perreault C, Jutras J, Roy DC et al. Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). J Clin Invest 1996; 98:622-8.
15. Mendoza LM, Paz P, Zuberi A et al. Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity 1997; 7:461-72.
16. Malarkannan S, Shich PP, Eden PA et al. The molecular and functional characterisation of a dominant minor H antigen, H60. J Immunol 1998; 161:3501-9.
17. Malarkannan S, Horng T, Eden P et al. Differences that matter: major cytotoxic T cell-stimulating minor histocompatibility antigens. Immunity 2000; 13:333-44.
18. Wettstein PJ. Immunodominance in the T-cell response to multiple histocompatibility antigens. II. Observation of a hierachy among dominant antigens. Immunogenetics 1986; 24:24-31.
19. Korngold R, Wettstein PJ. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J Immunol 1990; 145:4079-88.
20. Fontaine P, Langlais J, Perreault C. Evaluation of in vitro cytotoxic, T lymphocyte assays as predictive test for occurrence of graft-versus-host disease. Immunogenetics 1991; 34:222-6.
21. Fontaine P, Perreault C. Diagnosis of graft-versus-host disease in mice transplanted across minor histocompatibility barriers. Transplantation 1990; 49:1177-84.
22. Griem P, Wallny HJ, Falk K et al. Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression. Cell 1991; 65:633-40.
23. Ferrara JLM. Cytokine dysregulation as a mechanism of graft-versus-host disease. Curr Opin Immunol 1993; 5:794-9.
24. Bailey DW, Mobraaten LE. Estimates of the number of loci contributing to the histocompatibility between C57BL/6 and BALB/c strains of mice. Transplantation 1969; 7:394-1.
25. Wolpert E, Franksson L, Karrë K. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides. Int Immunol 1995; 5:1003-9.
26. Nevala WK, Wettstein P. Immunodominant minor histocompatibility antigen peptides presented by H2-Db molecules. Transplantation 1997; 64:1323-30.
27. Nevala WK, Wettsein PJ. The preferential response to immunodominant minor histocompatibility antigens. Transplantation 1996; 62:283-91.
28. David-Watine B, Israel A, Kourilsky P. The regulation and expression of MHC class I genes. Immunol Today 1990; 11:286-93.
29. Fontaine P, Roy-Proulx G, Knafo L et al. Adoptive transfer of minor histocompatibility antigens specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med 2001; 7:789-94.